Certoparin sodium

Certoparin sodium
Clinical data
Trade names	Sandoparin, Embolex
AHFS/Drugs.com	International Drug Names
ATC code	none;
Identifiers
CAS Number	9005-49-6 [ GSRS ];
DrugBank	DB09261 ;
ChemSpider	none;
UNII	V72OT3K19I ;
CompTox Dashboard (EPA)	DTXSID301010914 ;
ECHA InfoCard	100.110.590

Last updated January 03, 2026

Certoparin (trade names Sandoparin, Embolex) is an antithrombotic medication. It is a low molecular weight heparin, primarily active against factor Xa. Like other low molecular weight heparins, it is used to prevent deep venous thrombosis.^[1]

References

↑ Donadini MP, Ageno W, Guasti L, Squizzato A (July 2013). "Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies". Expert Opinion on Drug Metabolism & Toxicology. 9 (7): 901–9. doi:10.1517/17425255.2013.794787. PMID 23621639. S2CID 31020741.

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[pmid23621639-1] Donadini MP, Ageno W, Guasti L, Squizzato A (July 2013). "Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies". Expert Opinion on Drug Metabolism & Toxicology. 9 (7): 901–9. doi:10.1517/17425255.2013.794787. PMID 23621639. S2CID 31020741.

[1]